Markets: ResMed’s healthy advantage

A lower dollar and cheap offshore operating costs have contributed to ResMed's above-average returns, while its international competitors' revenues have shrunk.

Sleep apnea device maker ResMed Inc has given a rosy report to the market, with net profit for the year up 21 per cent to over $US 307 million and revenue up 11 per cent to $1.5 billion. In dollar terms it was record revenue and income for the quarter and fiscal year. Locally, the company's share price is up nearly 80 per cent over the past 12 months, easily leading its peers across the technology side of the healthcare industry.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles